99% Savings - Buy Just @1 Rs X
Monocef O CV 200/125 Tablet (10) is a prescription medicine that is available as a Tablet. Monocef O CV 200/125 Tablet (10) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Monocef O CV 200/125 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Monocef O CV 200/125 Tablet (10) can also lead to other problems, which have been listed below. Such side effects of Monocef O CV 200/125 Tablet (10) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Monocef O CV 200/125 Tablet (10) has a Mild effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Monocef O CV 200/125 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Monocef O CV 200/125 Tablet (10) related warnings section.
Monocef O CV 200/125 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Monocef O CV 200/125 Tablet (10) in conditions like Jaundice. The section on Monocef O CV 200/125 Tablet (10) contraindications lists all such conditions.
Drug interactions for Monocef O CV 200/125 Tablet (10) have been reported in the medical literature. See below for a complete list.
You should also be aware that Monocef O CV 200/125 Tablet (10) is safe while driving, and is addiction.
Monocef O CV 200/125 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Monocef O CV 200/125 Tablet (10) safe for pregnant women?
Pregnant women can consume [medicine]. Though Monocef O CV has mild side effects when taken during pregnany
Is the use of Monocef O CV 200/125 Tablet (10) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Monocef O CV. Immediately discontinue Monocef O CV if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Kidneys?
Kidney can be affected by Monocef O CV. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Liver?
You may experience side effects on your liver after taking Monocef O CV. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Heart?
Side effects of Monocef O CV rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Monocef O CV 200/125 Tablet (10) unless your doctor advises you to do so -
Is this Monocef O CV 200/125 Tablet (10) habit forming or addictive?
Monocef O CV 200/125 Tablet (10) does not cause addiction.
Interaction between Food and Monocef O CV 200/125 Tablet (10)
Taking Monocef O CV 200/125 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Monocef O CV 200/125 Tablet (10)
It is difficult to say anything about the effect of Monocef O CV 200/125 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311